Mayne Pharma | MYX - Loan Capital

Stock Price
4.50
Daily Change
-0.78 -14.77%
Monthly
-10.00%
Yearly
-6.44%
Q3 Forecast
5.25

Mayne Pharma reported AUD31.64M in Loan Capital for its fiscal semester ending in June of 2024.



Financials
Stock Price AUD
Assets AUD 1.14B
Cash and Equivalent AUD 110.07M
Cost of Sales AUD 43.74M
Current Assets AUD 460.59M
Current Liabilities AUD 313.94M
Debt AUD 38.82M
Dividend Yield 0
EBIT AUD -16.2M
EBITDA AUD -65.76M
Employees 900
EPS Earnings Per Share AUD -0.89
Equity Capital and Reserves AUD 454.19M
Gross Profit on Sales AUD 115.99M
Interest Expense on Debt AUD 1.2M
Loan Capital AUD 31.64M
Market Capitalization AUD 382.83M
Net Income AUD -103.68M
Operating Expenses AUD 103.54M
Operating Profit AUD -3.3M
Ordinary Share Capital AUD 1.22B
Pre-Tax Profit AUD -57.61M
Sales Revenues AUD 195.04M
Selling and Administration Expenses AUD 54.8M
Stock AUD 74.63M
Trade Creditors AUD 20.87M
Trade Debtors AUD 193.22M

Loan Capital Change Date
Ansell USD 706.6M 319.8M Jun/2024
Avita Medical AUD 42.24M 1.25M Dec/2024
Cochlear AUD 203.5M 1.4M Dec/2024
CSL USD 9.33B 1.91B Dec/2024
Healius AUD 1.22B 103M Dec/2024
Integral Diagnostics AUD 341.63M 1.98M Jun/2024
Medical Developments International AUD 1.76M 150K Dec/2024
Nanosonics AUD 5.78M 385K Dec/2024
Next Science USD 1.81M 1.24M Dec/2024
Polynovo AUD 12.84M 857K Jun/2024
Ramsay Health Care AUD 10.69B 359.3M Dec/2024
ResMed USD 658.39M 4.47M Jun/2025
Sigma Healthcare AUD 124.31M 2.53M Jul/2024
Sonic Healthcare AUD 4.19B 333.39M Dec/2024
Telix Pharmaceuticals AUD 551.82M 533.46M Dec/2024